共 1 条
Mixed-expired and end-tidal CO2 distinguish between ventilation and perfusion defects during exercise testing in patients with lung and heart diseases
被引:76
|作者:
Hansen, James E.
Ulubay, Gaye
Chow, Bing Fai
Sun, Xing-Guo
Wasserman, Karlman
机构:
[1] Univ Calif Los Angeles, Harbor Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA
[2] Univ Calif Los Angeles, Dept Med, Div Physiol & Med, Torrance, CA USA
[3] Baskent Univ, Fac Med, Dept Chest Dis, TR-06490 Ankara, Turkey
[4] Ruttonjee Hosp, Dept Resp Med, Hong Kong, Hong Kong, Peoples R China
来源:
关键词:
congestive heart failure;
COPD;
exercise test;
pulmonary artery hypertension;
pulmonary circulation;
ventilation/perfusion ratio;
D O I:
10.1378/chest.07-0619
中图分类号:
R4 [临床医学];
学科分类号:
1002 ;
100602 ;
摘要:
Background: Mismatching of ventilation to perfusion is found in patients with COPD, left ventricular failure (LVF), and pulmonary vascular diseases. Such mismatching may be due to ventilation or perfusion defects or both. Our primary hypothesis was that pressures of mixed-expired CO2 pressure (PECO2), end-tidal PCO2 pressure (PETCO2,), and their ratios would differ between groups during exercise testing, depending on whether the ventilation/perfusion (V/Q) abnormality was dominantly caused by airways or perfusion defects. Methods: We administered incremental cycle ergometry tests to 25 normal subjects and three groups of 25 patients, each group with uncomplicated COPD, LVF, or primary pulmonary arterial hypertension (PAH). We compared PECO2, PETCO2, and their ratios at rest, unloaded pedaling, anaerobic threshold, and peak exercise. Results: Although each patient group had mean peak 02 uptake of approximately 50% of predicted normal, the levels and patterns of change for each group for PECO2, PETCO2, and their ratios were surprisingly distinctive. As hypothesized, the COPD group always had markedly lower PECO2/PETCO2 ratios than all other groups (p < 0.001). In addition, patients with LVF had slightly lower PECO2/PETCO2 ratios at heavy exercise than normal subjects (p < 0.05). At all times, except for COPD group PETCO2 at peak exercise, each group had significantly lower PETCO2 and PECO2 than normal subjects (p < 0.001). In patients with PAH, the PETCO2 decline with exercise was distinctive. Conclusions: The levels and changes in PECO2,PETCO2, and their ratios during cardiopulmonary exercise testing are distinctive and explained by the differing pathophysiologies of V/Q mismatching in these disorders.
引用
收藏
页码:977 / 983
页数:7
相关论文